HIGHLIGHT
Spravato速開朗

Spravato Indications/Uses

esketamine

Manufacturer:

Janssen

Distributor:

DCH Auriga - Healthcare
Full Prescribing Info
Indications/Uses
Spravato, in combination with a SSRI or SNRI, is indicated for adults with treatment-resistant Major Depressive Disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode (see Pharmacology: Pharmacodynamics under Actions).
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in